FLGT
Fulgent Genetics IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$527.83M
P/E Ratio
—
EPS
$-2.40
Beta
0.92
52W High
$31.04
52W Low
$13.46
50-Day MA
$16.50
200-Day MA
$21.81
Dividend Yield
—
Profit Margin
-23.00%
Forward P/E
7.70
PEG Ratio
1.32
About Fulgent Genetics Inc
Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in Temple City, California.
Fundamentals
| Revenue (TTM) | $320.35M |
| Gross Profit (TTM) | $124.02M |
| EBITDA | $-77.19M |
| Operating Margin | -45.00% |
| Return on Equity | -6.92% |
| Return on Assets | -5.37% |
| Revenue/Share (TTM) | $10.40 |
| Book Value | $36.39 |
| Price-to-Book | 0.51 |
| Price-to-Sales (TTM) | 1.65 |
| EV/Revenue | 0.832 |
| EV/EBITDA | 2.34 |
| Quarterly Earnings Growth (YoY) | -98.60% |
| Quarterly Revenue Growth (YoY) | -3.20% |
| Shares Outstanding | $28.40M |
| Float | $17.56M |
| % Insiders | 36.66% |
| % Institutions | 63.39% |
Historical Volatility
HV 10-Day
53.54%
HV 20-Day
46.52%
HV 30-Day
50.62%
HV 60-Day
48.79%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($18.50 target)
1
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026